Invasive fungal infections and COVID-19: a review
Afr. J. Clin. Exp. Microbiol
;
23(1): 14-21, 2022. figures, tables
Artigo
em Inglês
| AIM
| ID: biblio-1355316
ABSTRACT
Invasive fungal diseases (IFDs) are major causes of morbidity and mortality among hospitalized patients all over the world with a global prevalence of 15%. Since the first case of COVID-19 was reported on February 27, 2020, in Nigeria, it had been discovered across all geopolitical zones in Nigeria. As the medical community confronts the ongoing COVID-19 pandemic, determining whether patients infected with SARS-CoV-2 develop fungal complications, especially invasive aspergillosis, is crucial. This review aimed to highlight the fungal co-infections that might be associated with SARS-CoV-2 infection, and modalities for their diagnosis, prevention, and management, with the view to reducing the high mortality associated with these infections
Texto completo:
DisponíveL
Índice:
AIM (África)
Assunto principal:
Infecções Fúngicas Invasivas
/
COVID-19
/
Antifúngicos
Tipo de estudo:
Fatores de risco
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Afr. J. Clin. Exp. Microbiol
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Department of Medical Microbiology and Immunology, Nile University of Nigeria/NG
/
Department of Medical Microbiology and Parasitology, University College Hospital/NG
Similares
MEDLINE
...
LILACS
LIS